Blackstone Inc vs Smith & Nephew plc — how do they compare? Blackstone Inc trades at $147.17 (market cap $113.32B), while Smith & Nephew plc trades at $30.05 (market cap $12.50B). The key difference: Blackstone Inc is far larger — about 9.1× Smith & Nephew plc's market cap, and Blackstone Inc pays the higher dividend (3.69%). Which is the better fit depends on your goals.
| BX | SNN | |
|---|---|---|
Market Cap | $113.32B | $12.50B |
Sector | Financials | Health |
52-Week High | $188.68 | $38.70 |
52-Week Low | $102.12 | $28.73 |
Dividend Yield | 3.69% | 2.64% |
Enterprise Value | — | $15.53B |
Trailing returns across standard periods
Latest headlines on both assets
Blackstone is one of the world's largest alternative asset managers with $940.8 billion in total asset under management, including $683.8 billion in fee-earning asset under management, at the end of June 2022.
Read more on BX →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →